Background: Oral corticosteroids (OCS) are widely prescribed for asthma exacerbations. Little is known of how intermittent OCS use relates to risk of adverse events (AEs).
|Publication status||Accepted/In press - 20 Aug 2021|
|Event||ERS International Congress 2021 - Virtual event|
Duration: 5 Sep 2021 → 8 Sep 2021
|Conference||ERS International Congress 2021|
|Period||5/09/21 → 8/09/21|